National Account Director

The National Account Director will own payer access and coverage strategy for assigned national and regional commercial payers, PBMs, Medicaid plans, Medicare, and integrated delivery networks. This is a field-based role responsible for securing appropriate coverage and reimbursement for Deramiocel, Capricor's lead cell therapy for Duchenne muscular dystrophy. This individual will partner closely with Market Access leadership, Trade & Patient Services, Medical Affairs, HEOR, Sales, and Patient Advocacy to translate the Deramiocel value proposition into coverage decisions, medical policy positions that support timely, equitable patient access in a high-cost, rare-disease, medical-benefit market. The position will engage senior payer decision-makers, deliver compelling clinical and economic value stories, navigate medical-benefit dynamics unique to infused cell therapies, and feed payer intelligence back into Capricor's launch and access strategy.